Latest filing published 18 Feb 2026 for Solid Biosciences Inc.. Read the official filing
No signal scores available.
Jessie Hanrahan discloses dealings in Solid Biosciences Inc. to SEC (Form 4). Over a trading history stretching from 2 December 2023 to 13 February 2026, the count stands at 7 filings.
Every open-market trade on record is a sale: 1 sale worth €67k. Besides market trades, the filings include 6 option exercises. 2026 to date brings no purchases and 1 sale.
The record was last updated on 18 February 2026 with an option exercise in Solid Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations